March 9, 2023, Pensacola, FL—Regenative Labs (Regenative), a leading HCT/P manufacturer, is pleased to announce the publication of its new… Read More >
Click Here to Read the Case Study Abstract This Institutional Review Board (IRB)-approved retrospective observational protocol aims to report the… Read More >
New data demonstrates statistically significant reported WOMAC improvement. February 20, 2023, Pensacola, FL – Regenative Labs (Regenative), a leading HCT/P… Read More >
January 19, 2023. Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have… Read More >
Click Here to Read the Case Study Abstract Each year, thousands of patients suffer from sacral decubitus ulcers, also known… Read More >
January 9, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal… Read More >
Click Here to Read the Case Study Abstract Nearly 15 million patients undergo cosmetic surgery in the United States each… Read More >
Click Here to Read and Download the Case Study RESEARCH ARTICLE Case study presented by Dr. Allen Meglin uncovers new… Read More >
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
We know physicians drive innovation in medicine, and we are dedicated to our data-driven, outcomes-focused approach to advance this field… Read More >